SEC Filing Details

Detailed Financial Reporting & Filings

Access Aprea Therapeutics’ quarterly and annual reports, earnings disclosures, and SEC filings. These financial documents reflect our commitment to transparency, regulatory compliance, and delivering clear insight into our operational and fiscal performance.

Document Details

Form
Filing Date
May 15, 2026
Document Date
May 15, 2026
Form Description
424B7    
Filing Group
Registration Statements
Company
Aprea Therapeutics
Issuer
Aprea Therapeutics, Inc.